Eir Ventures

Eir Ventures is a specialized venture capital firm, dedicated to financing and advancing innovative medicine within the life sciences sector. It invests in high-potential opportunities across biotechnology and pharmaceuticals, focusing on developing breakthrough therapies. The firm provides strategic capital, translating discoveries into medical solutions and accelerating clinical impact.

Established in 2020, Eir Ventures was founded on the insight that a strong Nordic base could effectively leverage global medical research for investment. Headquartered in Stockholm, Sweden, the firm maintains offices in Copenhagen, Denmark, and New Haven, USA, reflecting its broad network.

Eir Ventures partners with biotech and healthcare startups, from early-stage to mature companies. Its vision is to drive significant advancements in life sciences by supporting transformative therapy development. Integrating environmental, social, and governance principles, the firm aims to create lasting impact within the healthcare ecosystem and shape medicine’s future.